Tu, H., & Wu, Y. (2020). Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program. Onco Targets Ther.
Chicago Style CitationTu, Hai-Yan, i Yi-Long Wu. "Effect of Dose Adjustments On the Safety and Efficacy of Afatinib in Chinese Patients With EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program." Onco Targets Ther 2020.
Cita MLATu, Hai-Yan, i Yi-Long Wu. "Effect of Dose Adjustments On the Safety and Efficacy of Afatinib in Chinese Patients With EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program." Onco Targets Ther 2020.